Sachin Bhardwaj, MD
MOHS-Micrographic Surgery · Edina, MNNPI 1821038746
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 18 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Sanofi at 27.6% of the total. 2025 is the largest year on record at $133, 8.5 times the $16 reported in 2020. That places this record below the midpoint for mohs-micrographic surgery clinicians in MN, where the typical reported total is $427.
Across 18 payments — averaging $16.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$80
- LEO Pharma Inc.$45
- UCB, Inc.$43
- Incyte Corporation$34
- Regeneron Healthcare Solutions, Inc.$28
- Boehringer Ingelheim$21
- plus $41 from 3 others
What the payments were for
- Food & beverage$292100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 5 | $80 |
| LEO Pharma Inc. | 3 | $45 |
| UCB, Inc. | 2 | $43 |
| Incyte Corporation | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 2 | $28 |
| Boehringer Ingelheim | 1 | $21 |
| Johnson & Johnson | 1 | $14 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $13 |
| Biocon Biologics Inc | 1 | $13 |
How this compares
$292 in reported general payments places this provider in the 40th percentile of 29 mohs-micrographic surgery providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 181 | $764 |
| Gentamicin Sulfate | 16 | $518 |
| Mupirocin | 17 | $111 |
| Doxycycline Monohydrate | 14 | $79 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Edina
- Amanda TschetterEdina$478
- Whitney TopeEdina$275
- Ian MaherMinneapolis$18K
- Laura RezacRoseville$15K
- Edward SegerPlymouth$4K
- Addison DemerRochester$4K
- Anna-Bianca StashakRochester$902
- Ryan LaddRochester$808
- Bart EndrizziFridley$762
- Elliott CampbellRochester$732
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.